Stop Meth Labs and Enhance Patient Access Act of 2014
Do you support it?
Want to know if it passes?
We'll email you when HR 4502 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 4502.
You're tracking HR 4502
We'll email you the moment it moves.
HR 4502 — Stop Meth Labs and Enhance Patient Access Act of 2014
Last action — Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 113th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Stop Meth Labs and Enhance Patient Access Act of 2014 - Amends the Controlled Substances Act to authorize the Attorney General to exempt a scheduled listed chemical product from specified requirements regarding sales quantity, nonliquid forms, and retail transactions upon determining that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine (currently, upon determining that the product cannot be used in the illicit manufacture of methamphetamine).
Bill Text
We don't have the full text on file for this bill yet.
Read HR 4502 on the official United States source →Action History
-
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
-
Referred to the Subcommittee on Health.
-
Referred to House Judiciary
-
Referred to House Energy and Commerce
-
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
- Blaine Luetkemeyer · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 4502 do?
- Stop Meth Labs and Enhance Patient Access Act of 2014 - Amends the Controlled Substances Act to authorize the Attorney General to exempt a scheduled listed chemical product from specified requirements regarding sales quantity, nonliquid forms, and retail transactions upon determining that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine (currently, upon determining that the product cannot be used in the illicit manufacture of methamphetamine).
- Who sponsors HR 4502?
- HR 4502 is sponsored by Blaine Luetkemeyer (R).
- What is the current status of HR 4502?
- This bill died with 113th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 4502?
- Track HR 4502 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 4502
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 4502
Last checked for changes about 10 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →